Labeling is an crucial aspect of the deliver chain. This is particularly real for investigational clinical products (IMPs), which have to endure unambiguous expiration dates and different required facts. However, IMP shelf existence is notoriously difficult to calculate, and new information on their stability emerge frequently in the course of clinical trials. This often necessitates …